Search by Drug Name or NDC
NDC 00023-3348-07 OZURDEX 0.7 mg/1 Details
OZURDEX 0.7 mg/1
OZURDEX is a INTRAVITREAL IMPLANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is DEXAMETHASONE.
Product Information
NDC | 00023-3348 |
---|---|
Product ID | 0023-3348_9aafcf18-c506-4bd7-9521-de261a37626e |
Associated GPIs | 86300010002320 |
GCN Sequence Number | 065561 |
GCN Sequence Number Description | dexamethasone IMPLANT 0.7 MG INTRAOCULR |
HIC3 | Q6P |
HIC3 Description | EYE ANTI-INFLAMMATORY AGENTS |
GCN | 27558 |
HICL Sequence Number | 002889 |
HICL Sequence Number Description | DEXAMETHASONE |
Brand/Generic | Brand |
Proprietary Name | OZURDEX |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | dexamethasone |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | IMPLANT |
Route | INTRAVITREAL |
Active Ingredient Strength | 0.7 |
Active Ingredient Units | mg/1 |
Substance Name | DEXAMETHASONE |
Labeler Name | Allergan, Inc. |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA022315 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00023-3348-07 (00023334807)
NDC Package Code | 0023-3348-07 |
---|---|
Billing NDC | 00023334807 |
Package | 1 POUCH in 1 CARTON (0023-3348-07) / 1 IMPLANT in 1 POUCH |
Marketing Start Date | 2009-09-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |